Search

Search results

1. T Cell Depletion for Recipients of HLA Haploidentical Related Donor Stem Cell Grafts (MOHEL)

   For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov: ...

   Clinical Trial last updated 04/28/2016 - 12:15pm.

2. Administration of Donor Multi TAA-Specific T Cells for AML or MDS (ADSPAM)

   For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov: ...

   Clinical Trial last updated 04/28/2016 - 11:40am.

3. Donor Stem Cell Transplant With No or Low-Intensity Chemotherapy Using Sirolimus and Treated Immune Cells to Treat Blood and Lymph Cancers

   For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov: ...

   Clinical Trial last updated 04/28/2016 - 11:28am.

4. Pilot Study of Lupron to Improve Immune Function After Allogeneic Bone Marrow Transplantation

   For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov: ...

   Clinical Trial last updated 04/28/2016 - 11:14am.

5. Immunochemotherapy and AlloSCT in Patients With High Risk CD33+ AML/MDS

   For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov: ...

   Clinical Trial last updated 04/28/2016 - 11:08am.

6. CC-486 (Oral Azacitidine) Bioequivalence Study in Patients With Solid Tumor or Hematologic Malignancies

   For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov: ...

   Clinical Trial last updated 04/28/2016 - 10:47am.

7. Donor Lymphocyte Infusion With Azacitidine to Prevent Hematologic Malignancy Relapse After Stem Cell Transplantation

   For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov: ...

   Clinical Trial last updated 04/28/2016 - 10:42am.

8. Phase I Study of Velcade and Lenalidomide in Patients With Relapsed AML and MDS After Allogeneic Stem Cell Transplantation

   For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov: ...

   Clinical Trial last updated 04/28/2016 - 10:20am.

9. Study of a Novel BET Inhibitor FT-1101 in Patients With Relapsed/Refractory Acute Leukemia or High-Risk MDS

   For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov: ...

   Clinical Trial last updated 04/28/2016 - 9:55am.

10. Selinexor With Fludarabine and Cytarabine for Treatment of Refractory or Relapsed Leukemia or Myelodysplastic Syndrome

    For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov: ...

    Clinical Trial last updated 04/28/2016 - 9:48am.